Opioid Settlement
The State of Indiana has reached multiple settlements with major pharmaceutical companies, distributors, and related firms as part of the State’s ongoing commitment to accountability in addressing substance use. The settlements will provide Indiana with more than $980 million over an 18-year period.
The settlements are governed by Ind. Code §4-6-15, which defines the distribution structure, unless a settlement specifically prohibits or limits unrestricted use).
The Indiana Commission to Combat Substance Use Disorder has adopted the Johns Hopkins Bloomberg School of Public Health's Five Guiding Principles for the Use of Funds from the Opioid Litigation to guide Indiana's spending of the national settlements. The principles are as follows:
- Spend the money to save lives
- Use evidence to guide spending
- Invest in youth prevention
- Focus on racial equity
- Develop a fair and transparent process for deciding where to spend the funds.
On November 14, 2024, the Commission adopted recommendations for spending National Opioid Settlement funds. This resource aims to assist Indiana's local subdivisions in strategically allocating their 35% restricted distribution of opioid settlement funds received under Ind. Code §4-6-15. By utilizing this resource, communities can develop targeted plans of action to effectively address substance use disorder.
Access the recommendations here.
Indiana's Plan
The Office of Drug Prevention, Treatment, and Enforcement in partnership with the Indiana Family and Social Services Administration (FSSA) - Division of Mental Health and Addiction (DMHA) and the Indiana Department of Health (IDOH) have collaborated to develop a framework for how the State of Indiana will spend the state's 35% appropriation for abatement from national opioid settlements with opioid distributors, manufacturers, and marketers. Below are Indiana's plans for the 35% appropriated for abatement to the Indiana Family and Social Services Administration.
2024 Plan - Approved by State Budget Committee on August 22, 2024
2023 Plan - Approved by State Budget Committee on December 15, 2024
Reporting
Ind. Code 4-6-15-4 requires the Indiana Family and Social Services Administration (FSSA) to submit an annual comprehensive report of the use of all opioid settlement funds, including funds received by the local units of government, to the Indiana General Assembly by October 1. All local units of government that received funds from the National Opioid Settlement are required to report their use of funds to FSSA using an electronic reporting form distributed to all local units of government in August of each year. The information collected is included in a final report to the Indiana General Assembly and is made available to the public. Any questions regarding reporting should be directed to inopioidsettlement.us@egis-group.com.
The 2024 Opioid Settlement reporting period is closed.
View the 2024 report here.
- To see how each local unit of government reported their use of settlement funds, click here.
- To see how the State of Indiana reported its use of settlement funds, click here.
View the 2023 report here.
- To see how each local unit of government reported their use of settlement funds, click here.
State of Indiana Abatement Grant Recipients
In 2023 and 2024, the Indiana Family and Social Services Administration released four funding opportunities using the state's 35% abatement share of National Opioid Settlement funds. A summary of each Request for Funding is below, accompanied by a list of awardees for each opportunity.
Frequently Asked Questions
- How much money should my community expect to receive?
- How do I know if my community expects to receive funding?
- How will funds be distributed?
- When should Indiana expect to receive funds?
- How are funds being spent?
- Who is the point of contact?
- What are the requirements for reporting how funds are spent?
- How will Indiana be transparent?
Additional Resources
- National Opioid Settlement
- Office of the Attorney General - Complex Litigation
- Division of Mental Health and Addiction - Funding Announcements
Contact Us
Questions? Contact us at drugpte@gov.in.gov.